Related Experiment Video

Updated: Apr 5, 2026

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

2.4K

Role of PAR-4 in ovarian cancer

Sonia Meynier1, Marianne Kramer1, Pascale Ribaux1

  • 1Department of Gynecology Obstetrics, Faculty of Medicine, University of Geneva, Switzerland.

Oncotarget
|August 7, 2015
PubMed

Insights

Prostate apoptosis response-4 (PAR-4) shows promise as a therapeutic target in ovarian cancer. This study found PAR-4 induces apoptosis and reduces tumor growth, suggesting its potential in treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Prostate apoptosis response-4 (PAR-4) is a known tumor suppressor inducing apoptosis in cancer cells.
  • The role of PAR-4 in ovarian cancer development and progression remains largely uncharacterized.

Purpose of the Study:

  • To investigate the role of PAR-4 in ovarian carcinogenesis.
  • To evaluate PAR-4 as a potential therapeutic target for ovarian cancer.

Main Methods:

  • Quantitative analysis of PAR-4 mRNA levels in healthy and cancerous ovarian tissues.
  • Immunohistochemical staining for PAR-4 protein localization in ovarian tissues.
  • In vitro apoptosis assays and GRP78 relocation studies in SKOV-3 ovarian cancer cells.
  • In ovo assessment of PAR-4's effect on tumor development and chemosensitivity.

Main Results:

  • PAR-4 mRNA levels did not significantly differ between healthy and cancerous ovarian cells.
  • Ovarian cancer cells exhibited positive nuclear and cytoplasmic PAR-4 staining, unlike healthy cells.
  • PAR-4 induced apoptosis in vitro and promoted GRP78 relocation to the cell surface in SKOV-3 cells.
  • In ovo, PAR-4 reduced ovarian tumor growth and enhanced taxol treatment efficacy.

Conclusions:

  • PAR-4 plays a significant role in ovarian carcinogenesis.
  • PAR-4 induces apoptosis and influences GRP78 localization in ovarian cancer cells.
  • PAR-4 represents a promising therapeutic target for ovarian cancer treatment.
Keywords:
GRP78PAR-4apoptosisovarian cancer

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K